Skip to content
Back to news

Celebrating SRIMC: A Decade of Innovation in Chemistry

Launched in 2007 in Budapest, SRIMC started with a team of over 20 colleagues dedicated to the chemical support of original drug discovery. Fast forward to today, SRIMC has grown to a robust team of over 50 highly qualified researchers, mainly chemists, chemical engineers or pharmacists, making it a leading player in our discovery chemistry research.

The institute’s activities are diverse and comprehensive, covering everything from validating chemistry starting points to developing lead molecules into drug candidates. SRIMC is also an innovation driver in emerging areas such as biocatalysis and targeted protein degradation. Its Process Chemistry division facilitates transition to CMC (Chemistry and Manufacturing Controls), while the Analytical division plays a crucial role in ensuring quality control throughout the research and development chain.

5

preclinical candidates

2

clinical candidates

20+

patents

20+

scientific publications in renowned journals (Nature, Journal of the American Chemical Society -JACS, Chemistry)

But SRIMC is not just about research, it’s also about fostering the next generation of scientists. With 10 to 15 students and doctoral candidates, the SRIMC plays an important role in training the next generation of professionals. Over the past decade, many students have had the opportunity to learn about drug discovery in the institute’s laboratories, which are internationally renowned for their facilities.

The award from the Hungarian Academy of Sciences is a fitting recognition of SRIMC’s decade-long journey of excellence. It celebrates not only the Institute’s unwavering dedication to medicinal chemistry, but also its ongoing commitment to therapeutic innovation for the benefit of patients.

20%

We invest over 20% of our revenue from brand-name medicines in R&D each year.